Boston Clinically Validated Equipment & Supplies

1 equipment items found

Boston - Model BOS-475 - Bromodomain and Extra Terminal (BET) Inhibitor

Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)

BOS-475 is a selective BET (bromodomain and extra terminal) inhibitor. BOS-475 potently inhibits multiple clinically validated pathways (IL-12/IL-23-p40, Th17 cytokines and TNF) relevant to psoriasis pathophysiology. BOS-475 demonstrates broad inhibitory activities on other key disease-relevant immune-inflammatory mediators such as MCP-1, IL-6, and CXCL10 & ...

CONTACT SUPPLIER

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you